It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Studies show vaccines are effective against delta variant

World / Science & Health Jul 7, 2021

Studies show vaccines are effective against delta variant

by Carl Zimmer

Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.

Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths

World Jun 20, 2021

Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths

In Sao Paulo, people demand the U.S. company’s shots at public clinics and often walk out if none are available.

Don’t count on needing a COVID-19 booster shot, top WHO scientist says

World / Science & Health Jun 20, 2021

Don’t count on needing a COVID-19 booster shot, top WHO scientist says

by Jason Gale

As some governments prepare for COVID-19 booster shots targeting more infectious virus variants, health authorities say it’s too early to tell if they will be required.

Regeneron drug reduces COVID-19 patient deaths in large study

World / Science & Health Jun 16, 2021

Regeneron drug reduces COVID-19 patient deaths in large study

The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company’s casirivimab and imdevimab combination of monoclonal antibodies.

Why Asia, the pandemic champion, remains miles away from the finish line

Asia Pacific Jun 16, 2021

Why Asia, the pandemic champion, remains miles away from the finish line

by Damien Cave

All across the Asia-Pacific region, the countries that led the world in containing the coronavirus are now languishing in the race to put it behind them.

Novavax COVID-19 shot highly effective against variants in trial

World Jun 15, 2021

Novavax COVID-19 shot highly effective against variants in trial

by Todd Gillespie and Robert Langreth

The company plans to apply for regulatory clearance globally, with much of the first available doses going to low- and middle-income countries.

Japan weighs approving Moderna's COVID-19 vaccine for ages 12 to 17

National Jun 11, 2021

Japan weighs approving Moderna's COVID-19 vaccine for ages 12 to 17

The vaccine would become the second available to adolescents in the country after Pfizer Inc. received approval in late May.

U.S. FDA faces mounting criticism over Alzheimer's drug approval

World / Science & Health | ANALYSIS Jun 11, 2021

U.S. FDA faces mounting criticism over Alzheimer's drug approval

by Deena Beasley and Julie Steenhuysen

The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.

Eisai sees potential of new Alzheimer's drug but costs remain concern

Business Jun 9, 2021

Eisai sees potential of new Alzheimer's drug but costs remain concern

The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.

Biggest vaccine-maker’s problems keep world short of COVID-19 shots

World Jun 9, 2021

Biggest vaccine-maker’s problems keep world short of COVID-19 shots

by Chris Kay and P.R. Sanjai

The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.

Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug

National / Science & Health Jun 8, 2021

Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug

by Robert Langreth

The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.

Chinese drugmakers take aim at lucrative U.S. anti-cancer market

Business | FOCUS Jun 4, 2021

Chinese drugmakers take aim at lucrative U.S. anti-cancer market

In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.

« 1 … 12 13 14 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times